Orinda, CA, United States of America

Lennart Olsson

This inventor holds 11 USPTO granted patents. Top assignees: Receptron, Inc., University of California, Reception, Inc.. Active years: 1991-2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lennart Olsson. Retrieved from https://idiyas.com/inventor/lennart-olsson-4ync5214

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 1.8

ph-index = 4

Forward Citations = 76(Granted Patents)


Company Filing History:


Years Active: 1991-2006

Loading Chart...
11 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Inventor Lennart Olsson

Introduction: Lennart Olsson, located in Orinda, California, is a prolific inventor with a remarkable portfolio of 11 patents. His work primarily focuses on advancements in receptor biology and therapeutic applications. This article highlights his latest patents, career milestones, and collaborations with fellow innovators in the field.

Latest Patents: Olsson's recent patents showcase his dedication to developing compounds with significant medical applications. One key patent involves affinity small molecules for the erythropoietin receptor (EPO-R). These compounds are designed to complex with the modulating domain of EPO-R, which is crucial for determining the presence of EPO-R and assessing the ability of other molecules to engage with it in competitive assays. The compounds are noted for featuring a six-membered heterocyclic ring with at least one nitrogen atom, including substituted triazolopyrimidine, pyridazinone, pyridine, and piperidine structures.

Another notable patent focuses on receptor-derived peptides that modulate response to ligand binding. These oligopeptides, which have sequences corresponding to the extracellular domains of receptors and similarities to regulatory peptides from MHC class I antigens, enhance physiological responses when ligands bind to the related receptors. The implications of this work span diagnostics and therapies for diseases that exhibit inadequate receptor responses and drug candidate screening that impacts receptor surface expression.

Career Highlights: Throughout his career, Lennart Olsson has worked with esteemed organizations such as Receptron, Inc. and the University of California. His contributions have significantly shaped the understanding of receptor biology and therapeutic methodologies.

Collaborations: Olsson's work has led to fruitful collaborations with notable figures in the field, including Robert S. Goodenow and Avram Goldstein. These partnerships have enriched his research and expanded the scope of his inventions.

Conclusion: Lennart Olsson stands out as a significant figure in the field of innovation, particularly in receptor biology and therapeutic applications. His inventive contributions, alongside his collaborations, continue to have a lasting impact on medical science and the development of new treatments. Through his 11 patents, he demonstrates a commitment to advancing knowledge and technology in the realm of healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…